Manager, Biospecimen Lead at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Clinical ResearchIndustries

Requirements

Scientific degree (Associates, Bachelors, Masters, or higher), Project management or equivalent experience
3+ years academic, biotech, healthcare or pharmaceutical industry experience or equivalent
Intermediate knowledge of clinical biospecimen procedures and lifecycle including: collection and tracking procedures, logistics considerations, chain of custody, issue escalation/resolution and data management
Intermediate vendor experience (e.g., Central Labs, Bioanalytical, Biomarker, CROs, Biospecimen Storage Vendors, etc.)
Able to support 5-12 clinical trials, Phase I-IV, ranging from low to high complexity and prioritize tasks to meet company objectives
Effective communication skills. Able to create and deliver presentation/information/data to knowledgeable audiences, with limited supervision
Demonstrates change Agility through willingness to pivot current ways to working to new model(s)
Basic understanding of clinical and biomedical research

Responsibilities

Oversee biospecimen management in 5-12 clinical trials, with minimal supervision
Develop Specimen Management Plan, highlighting risks and providing mitigations steps
Provide biospecimen input in protocol authoring to ensure operational feasibility and regulatory compliance
Track and reconcile biospecimen status using internal and external systems
Enter biospecimen requirements into a contracting system and ensure vendor documents (e.g. lab manuals, lab specs) are aligned with protocol and sample management plan
Provide regular biospecimen status updates to core clinical team (inventory, location, quality issues, timelines)
Adhere to standard operating procedures and guidance documents
Act as a liaison between clinical teams and vendors to coordinate biospecimen activities and resolve issues with minimal supervision
Participate in vendor audits and assist with CAPA resolutions
Maintain study documents in ‘inspection ready’ state
Participate in cross-functional projects aimed at optimizing workflows and integrating innovative technologies
Provide training and mentorship for new colleagues
Maintain intermediate knowledge of therapeutic area and study related biospecimen requirements

Skills

biospecimen management

clinical trials

specimen management plan

cross-functional collaboration

risk mitigation

Phase 1-4 trials

clinical team coordination

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free